March 14 (Reuters) - All drug manufacturers, including
Novo Nordisk and Teva Pharmaceuticals,
whose medicines are part of the second round of price talks have
agreed to participate in the negotiation process, a federal
health agency said on Friday.
(Reporting by Bhanvi Satija and Sneha SK in Bengaluru)